Taisuke Mori

23PUBLICATIONS
29CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 21, 2026
Late-Onset Bilateral Malignant Ciliary Body Medulloepithelioma in an Adult.

Yuto Kaimi, Shigenobu Suzuki, Toshihide Ueno

|Dec 03, 2025
Abnormal nuclear and nucleolar immunoreactivity of p16INK4a represents a frameshift alteration in CDKN2A: the E6H4 clone recognizes the "p14ARF::p16INK4a" chimeric protein.

Ayaka Mitsui, Jumpei Kashima, Eijitu Ryo

|May 20, 2025
Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy.

Tomomi Sanomachi, Tatsunori Shimoi, Yuki Kojima

|Jan 22, 2025
Relationship Between Short-Term Outcomes and PD-L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti-PD-1 Antibody Monotherapy.

Akihiro Ohara, Taisuke Mori, Mai Itoyama

|Nov 15, 2024
Pediatric Mesenchymal Tumor With MN1::TAF3 Fusion.

Chikako Sato, Masanaka Sugiyama, Taisuke Mori

|Sep 27, 2024
Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour.

Naoki Kojima, Shogo Nishino, Yukiko Sasahara

Pageof 4

Frequent Collaborators

6 joint publications

Yasushi Yatabe

4 joint publications

Akihiko Yoshida

2 joint publications

Dai Ogata

2 joint publications

Naoya Yamazaki